Aripiprazole associated urine retention in a male schizophrenia patient.
Urine retention and voiding dysfunction are infrequent adverse effects in second generation antipsychotics. We present a male patient who developed voiding difficulties after aripiprazole treatment. Close follow-up of a patient after initiating aripiprazole treatment is critical. Lowering the dosage of aripiprazole or changing the antipsychotic medication might be helpful in this situation.
Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, LuKang, Taiwan; Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan; Department of Clinical Psychiatry, Chung Shan Medical University, Taichung, Taiwan; Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
Wen-Yu
WY
Hsu
Ting-Gang
TG
Chang
Nan-Ying
NY
Chiu
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D000068180:Aripiprazole; D006801:Humans; D008297:Male; D010879:Piperazines / Q000009:adverse effects*; D015363:Quinolones / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy*; D016055:Urinary Retention / Q000139:chemically induced*
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole
5-HT; Aripiprazole; Urine retention